Exact Mass: 744.2781774
Exact Mass Matches: 744.2781774
Found 21 metabolites which its exact mass value is equals to given mass value 744.2781774,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(+)-lyoniresinol 2a-O-alpha-D-galactopyranosyl-3a-O-beta-D-glucopyranoside
(+)-lyoniresinol 2a-O-alpha-D-galactopyranosyl-3a-O-beta-D-glucopyranoside
(3R,4R)-2-hydroxy-3,4-bis(3,5-dimethoxy-4-beta-D-glucopyranosiloxybenzyl)tetrahydrofuran
(3R,4R)-2-hydroxy-3,4-bis(3,5-dimethoxy-4-beta-D-glucopyranosiloxybenzyl)tetrahydrofuran
(+)-lyoniresinol 9-O-beta-D-glucopyranosyl-(1<*>4)-beta-D-glucopyranoside|(+)-lyoniresinol 9-O-beta-D-glucopyranosyl-(1[*]4)-beta-D-glucopyranoside
(+)-lyoniresinol 9-O-beta-D-glucopyranosyl-(1<*>4)-beta-D-glucopyranoside|(+)-lyoniresinol 9-O-beta-D-glucopyranosyl-(1[*]4)-beta-D-glucopyranoside
(+)-lyoniresinol 4,4-bis-O-beta-D-glucopyranoside|(-)-Lyoniresinol-4,4-bis-O-??-D-glucopyranoside
(+)-lyoniresinol 4,4-bis-O-beta-D-glucopyranoside|(-)-Lyoniresinol-4,4-bis-O-??-D-glucopyranoside
(+)-lyoniresinol 9-O-beta-D-glucopyranosyl-(1?3)-beta-D-glucopyranoside|pteleifoside G
(+)-lyoniresinol 9-O-beta-D-glucopyranosyl-(1?3)-beta-D-glucopyranoside|pteleifoside G
(-)-(8R,7E)-4-hydroxy-3,3,5,5-tetramethoxy-8,4-oxyneolign-7-ene-9,9-diol 4,9-bis-O-beta-D-glucopyranoside
(-)-(8R,7E)-4-hydroxy-3,3,5,5-tetramethoxy-8,4-oxyneolign-7-ene-9,9-diol 4,9-bis-O-beta-D-glucopyranoside
(+)-lyoniresinol 3a-O-alpha-D-galactopyranosyl-(1->6)-beta-D-glucopyranoside
(+)-lyoniresinol 3a-O-alpha-D-galactopyranosyl-(1->6)-beta-D-glucopyranoside
Orvepitant maleate
Orvepitant maleate
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Orvepitant maleate (GW823296 maleate) is potent, selective, orally active and well-tolerated neurokinin-1 receptor (NK-1) antagonist with a pKi of 10.2 for human neurokinin-1 receptor. Orvepitant maleate can across the blood-brain barrier. Orvepitant maleate has the potential for depressive disorder and chronic refractory cough (CRC) treatment[1][2].
(+)-lyoniresinol 4,4-bis-O-beta-D-glucopyranoside
(+)-lyoniresinol 4,4-bis-O-beta-D-glucopyranoside
A lignan that consists of (+)-lyoniresinol attached to two beta-D-glucopyranosyl units at positions 4 and 4 via glycosidic linkages. Isolated from Indigofera heterantha, it exhibits inhibitory activity against lipoxygenase.
2-[(4,5-dihydroxy-6-{[7-hydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy}-2-(hydroxymethyl)oxan-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
2-[(4,5-dihydroxy-6-{[7-hydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy}-2-(hydroxymethyl)oxan-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
2-{[8-(4-hydroxy-3,5-dimethoxyphenyl)-6-(hydroxymethyl)-1,3-dimethoxy-7-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-{[8-(4-hydroxy-3,5-dimethoxyphenyl)-6-(hydroxymethyl)-1,3-dimethoxy-7-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(6r,7r,8s)-8-(4-hydroxy-3,5-dimethoxyphenyl)-6-(hydroxymethyl)-1,3-dimethoxy-7-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(6r,7r,8s)-8-(4-hydroxy-3,5-dimethoxyphenyl)-6-(hydroxymethyl)-1,3-dimethoxy-7-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(2r,3s,4r,5r,6r)-4,5-dihydroxy-6-{[(1s,2r,3r)-7-hydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(2r,3s,4r,5r,6r)-4,5-dihydroxy-6-{[(1s,2r,3r)-7-hydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-(4-{[(2s,3s,4s)-4-[(3,5-dimethoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl]-2-hydroxyoxolan-3-yl]methyl}-2,6-dimethoxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-(4-{[(2s,3s,4s)-4-[(3,5-dimethoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl]-2-hydroxyoxolan-3-yl]methyl}-2,6-dimethoxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
2-(4-{4-[(3,5-dimethoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl}-2,6-dimethoxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
2-(4-{4-[(3,5-dimethoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl}-2,6-dimethoxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
2-[4-({4-[(3,5-dimethoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl]-2-hydroxyoxolan-3-yl}methyl)-2,6-dimethoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
2-[4-({4-[(3,5-dimethoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl]-2-hydroxyoxolan-3-yl}methyl)-2,6-dimethoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{4-[(2s,3r,4r)-4-[(3,5-dimethoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl]-2,6-dimethoxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{4-[(2s,3r,4r)-4-[(3,5-dimethoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl]-2,6-dimethoxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol